InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.140
+0.060 (5.56%)
At close: Dec 24, 2025, 1:00 PM EST
1.100
-0.040 (-3.49%)
After-hours: Dec 24, 2025, 4:48 PM EST
InflaRx Market Cap
InflaRx has a market cap or net worth of $77.23 million as of December 24, 2025. Its market cap has decreased by -48.95% in one year.
Market Cap
77.23M
Enterprise Value
26.31M
1-Year Change
-48.95%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $77.23M, a decrease of -77.99%. That is a compound annual growth rate of -16.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 77.20M | -46.91% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |